Dr. Chaudhary is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
785 Medical Center Drive West
Suite 203
Clovis, CA 93611Phone+1 559-387-1900Fax+1 559-387-1950
Education & Training
University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 1997 - 2000
Indiana University School of MedicineResidency, Internal Medicine, 1994 - 1997
Aga Khan Medical CollegeClass of 1992
Certifications & Licensure
CA State Medical License 2009 - 2026
SC State Medical License 2000 - 2009- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Gemcitabine and Irinotecan in Treating Patients With Locally Advanced Unresectable or Metastatic Kidney Cancer Start of enrollment: 2003 Sep 01
- Gemcitabine and Irinotecan in Treating Patients With Locally Advanced or Metastatic Bladder Cancer Start of enrollment: 2001 Nov 01
- PEG-Interferon Alfa-2b, Sargramostim, and Thalidomide in Treating Patients With Metastatic Kidney Cancer Start of enrollment: 2002 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- Unusual sites of hepatocellular carcinoma metastasis: Case report.Hunza Chaudhry, Aalam Sohal, Humzah Iqbal, Uzair Chaudhary, Marina Roytman
SAGE Open Medical Case Reports. 2023-01-01 - 1 citationsA Case of a Rare Parathyroid Hormone (PTH)-Producing Neuroendocrine Tumor.Catherine Dianne Quinn, Fihr Chaudhary, Aron Gould-Simon, Baorong Chen, Harsimran Singh Bhandal
The American Journal of Case Reports. 2022-07-18 - 1 citationsDigital ischaemia and necrosis from oxaliplatin.Charity Huang, Leslie Storey, Uzair Chaudhary
BMJ Case Reports. 2022-02-07
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
